Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,282 | -4,799 | -1,452 | -16,609 | -12,731 |
| Depreciation Amortization | 696 | 473 | 244 | 1,038 | 796 |
| Accounts receivable | 139 | 150 | 150 | -150 | -5 |
| Accounts payable and accrued liabilities | -252 | -299 | -100 | -110 | 29 |
| Other Working Capital | 166 | 62 | -344 | -372 | -190 |
| Other Operating Activity | 1,049 | 806 | 335 | 2,110 | 1,472 |
| Operating Cash Flow | $-6,484 | $-3,607 | $-1,167 | $-14,093 | $-10,629 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -11 | -8 | -482 | -424 |
| Other Investing Activity | 0 | 0 | 0 | -57 | -57 |
| Investing Cash Flow | $-12 | $-11 | $-8 | $-539 | $-481 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,102 | 3,102 | N/A | 9 | 9 |
| Financing Cash Flow | $3,102 | $3,102 | $N/A | $9 | $9 |
| Exchange Rate Effect | 32 | 41 | 1 | -142 | -202 |
| Beginning Cash Position | 11,909 | 11,909 | 11,909 | 26,674 | 26,674 |
| End Cash Position | 8,547 | 11,434 | 10,735 | 11,909 | 15,371 |
| Net Cash Flow | $-3,362 | $-475 | $-1,174 | $-14,765 | $-11,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,484 | -3,607 | -1,167 | -14,093 | -10,629 |
| Capital Expenditure | -13 | -12 | -9 | -483 | -424 |
| Free Cash Flow | -6,497 | -3,619 | -1,176 | -14,576 | -11,053 |